Department of Physiotherapy, University of Malaga, Malaga, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain.
Department of Physiotherapy, University of Malaga, Malaga, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Malaga, Spain.
Exp Gerontol. 2021 Aug;151:111420. doi: 10.1016/j.exger.2021.111420. Epub 2021 May 23.
In 2018, the European Working Group on Sarcopenia in Older People (EWGSOP) updated the definition and the diagnosis criteria of sarcopenia. Previous systematic reviews have shown the effect of exercise on sarcopenia including people with different sarcopenia diagnostic criteria.
This systematic review and meta-analysis aims to summarise and synthesise the evidence about the effect of exercise on muscle mass, strength and physical performance in older adults with sarcopenia according to the EWGSOP criteria.
Major electronic databases were searched for articles published until September 2020. Randomised controlled trials (RCTs) and non-randomised interventional studies examining the effect of exercise on muscle mass, strength or physical performance in adults older than 60 years with sarcopenia according to the EWGSOP criteria were included.
Four RCTs and three non-randomised interventional studies with a total of 235 patients with sarcopenia were included. Five of the seven included studies reported a low risk of bias. Exercise showed a large effect on physical performance (d = 1.21, 95%CI [0.79 to 1.62]; P < 0.001), a medium effect on muscle strength (d = 0.51, 95%CI [0.25 to 0.76]; P < 0.001), and no effect on muscle mass (d = 0.27, 95%CI [-0.05 to 0.58]; P = 0.10).
The present systematic review showed an effect of exercise on physical performance and muscle strength but an inconsistent effect on muscle mass. The grading of recommendations assessment, development and evaluation criteria showed a low level of evidence in muscle mass, a low or moderate level of evidence in muscle strength and a high level of evidence in physical performance.
2018 年,欧洲老年人肌肉减少症工作组(EWGSOP)更新了肌肉减少症的定义和诊断标准。之前的系统评价已经表明,运动对包括使用不同肌肉减少症诊断标准的人群在内的肌肉减少症有影响。
本系统评价和荟萃分析旨在总结和综合根据 EWGSOP 标准评估运动对老年人肌肉减少症患者肌肉量、力量和身体机能的影响的证据。
检索了截至 2020 年 9 月发表的主要电子数据库中的文章。纳入了随机对照试验(RCT)和非随机干预研究,这些研究检查了根据 EWGSOP 标准诊断为肌肉减少症的 60 岁以上成年人的运动对肌肉量、力量或身体机能的影响。
纳入了 4 项 RCT 和 3 项非随机干预研究,共纳入了 235 例肌肉减少症患者。其中 7 项研究中有 5 项报告了低偏倚风险。运动对身体机能有较大影响(d=1.21,95%CI [0.79 至 1.62];P<0.001),对肌肉力量有中等影响(d=0.51,95%CI [0.25 至 0.76];P<0.001),对肌肉量无影响(d=0.27,95%CI [-0.05 至 0.58];P=0.10)。
本系统评价显示,运动对身体机能和肌肉力量有影响,但对肌肉量的影响不一致。推荐评估、制定和评估标准的分级显示,肌肉量的证据水平较低,肌肉力量的证据水平为低或中等,身体机能的证据水平为高。